Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5 - Concepedia

Concepedia

Publication | Open Access

Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5

DOI Full Paper Access

53

Citations

25

References

2020

Year

Christelle Dufour, Stéphanie Foulon, Anne Geoffray, Julien Masliah‐Planchon, Dominique Figarella‐Branger, Valérie Bernier‐Chastagner, Laëtitia Padovani, Léa Guerrini‐Rousseau, Cécile Faure‐Conter, Céline Icher,

Abstract

This treatment based on high-dose chemotherapy and conventional radiotherapy resulted in a high survival rate in children with newly diagnosed high-risk medulloblastoma.

References

	Year	Citations

Page 1